Product Description: Fontolizumab (HuZAF) is a humanized monoclonal anti-IFN-gamma antibody. Fontolizumab is an immunosuppressive agent. Fontolizumab can be used in research of Crohn’s disease[1].
Applications: COVID-19-immunoregulation
Formula: N/A
References: [1]Hommes DW, et, al. Fontolizumab, a humanised anti-interferon gamma antibody, demonstrates safety and clinical activity in patients with moderate to severe Crohn's disease. Gut. 2006 Aug;55(8):1131-7.
CAS Number: 326859-36-3
Molecular Weight: N/A
Compound Purity: 97.18
Research Area: Inflammation/Immunology
Solubility: 10 mM in DMSO
Target: IFNAR